跳至主要内容
临床试验/NCT04488744
NCT04488744已完成早期 1 期

Modeling Tobacco Smoking by IV Pulsed Nicotine in Smokers

Yale University1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2019年11月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
13
试验地点
1
主要终点
Heart rate will be used to see the dose effect

研究概览

简要总结

To establish a dose-effect curve for nicotine's abuse potential as a function of nicotine dose and delivery rate. Pulsed IV nicotine administration will be used as it closely matches nicotine delivery by inhaled tobacco use.

详细描述

Both sub-studies will enroll male and female tobacco cigarette smokers. This study will examine the feasibility of the proposed study parameters in a total of 10 completers. In a crossover design, participants will be tested under 5 conditions: 0.2 mg nicotine delivered over 2.5 minutes (5 pulsed-nicotine deliveries), 0.2mg nicotine delivered over 10 min (20 pulsed-nicotine deliveries), 1.0 mg nicotine delivered over 2.5 minutes (5 pulsed-nicotine deliveries) and 1.0 mg nicotine delivered over 10 min (20 pulsed-nicotine deliveries). The main outcome measures will be self-report drug effects and urges to smoke cigarettes.

The investigators hypothesize that the abuse potential and alleviation of smoking urges are produced by nicotine as a function of nicotine dose and delivery rate.

This study is complete with 13 enrolled and 10 completers

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

盲法说明

Participant will not know nicotine dose or rate of infusion.

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Female and male smokers, aged 18 to 35 years, who have been smoking tobacco cigarettes for at least a year
  • smoke ≥ 5 and less than 20 cigarettes per day
  • urine cotinine levels > 100 ng/mL consistent with nicotine intake of an active smoker
  • not seeking treatment at the time of the study for nicotine dependence
  • in good health as verified by medical history, screening examination, and screening laboratory tests; and 6) for women, not pregnant as determined by pregnancy screening, nor breast feeding, and using acceptable birth control methods.

排除标准

  • History of major medical or psychiatric disorders that the physician investigator deems as contraindicated for the subject to be in the study
  • regular use of psychotropic medication (antidepressants, antipsychotics, or anxiolytics)
  • current alcohol or substance dependence for any other recreational or prescription drugs other than nicotine
  • use of e-cigarettes more than 10 days in the past 30 days
  • urine drug screening indicating recent illicit drugs use (with the exception of marijuana)

研究组 & 干预措施

nicotine infusion 0.2mg

Experimental

nicotine infusion

0.2 mg nicotine delivered over 2.5 minutes (5 pulsed-nicotine deliveries) The day order will be randomized over 5 days.

干预措施: Nicotine 0.2mcg/kg/s and 1.0mcg/kg/s (Drug)

nicotine infusion 2.0mg

Experimental

0.2mg nicotine delivered over 10 min (20 pulsed-nicotine deliveries),

干预措施: Nicotine 0.2mcg/kg/s and 1.0mcg/kg/s (Drug)

nicotine infusion 1.0mg

Experimental

1.0 mg nicotine delivered over 2.5 minutes (5 pulsed-nicotine deliveries)

干预措施: Nicotine 0.2mcg/kg/s and 1.0mcg/kg/s (Drug)

nicotine infuison 1.0mg

Experimental

1.0 mg nicotine delivered over 10 min (20 pulsed-nicotine deliveries).

干预措施: Nicotine 0.2mcg/kg/s and 1.0mcg/kg/s (Drug)

Saline

Placebo Comparator

saline delivered over 2minutes ,2.5minutes,10 minutes

干预措施: Nicotine 0.2mcg/kg/s and 1.0mcg/kg/s (Drug)

结局指标

主要结局

Heart rate will be used to see the dose effect

时间窗: During nicotine infusion max of ten minutes

the dose-effect curves of nicotine dose and delivery rate in heart rate

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mehmet Sofuoglu

Professor of Psychiatry

Yale University

研究点 (1)

Loading locations...

相似试验